NEAT1 and hepatocellular carcinoma: There was only one eligible study exploring the prognostic role of NEAT1 in GC and HCC, and the HRs were 1.61 (95% CI: 1.03-2.53, P = 0.038) and 1.93 (95% CI: 0.5-7.36, P = 0.338), respectively.